Posted by admin on Jun 24th, 2022
Retractable Technologies, Inc. (NYSEAMERICAN:RVP – Get Rating) passed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $0.00 and traded as high as $3.94. Retractable Technologies shares last traded at $3.92, with a volume of 172,467 shares.
The firm has a market capitalization of $129.11 million, a P/E ratio of 2.86 and a beta of 1.89. The company has a quick ratio of 1.92, a current ratio of 2.44 and a debt-to-equity ratio of 0.02.
Retractable Technologies (NYSEAMERICAN:RVP – Get Rating) last announced its earnings results on Tuesday, May 17th. The company reported $0.22 earnings per share (EPS) for the quarter. The business had revenue of $44.74 million for the quarter. Retractable Technologies had a return on equity of 68.86% and a net margin of 28.99%.
In other news, major shareholder Braden Michael Leonard bought 156,070 shares of Retractable Technologies stock in a transaction that occurred on Thursday, April 28th. The stock was bought at an average price of $3.58 per share, for a total transaction of $558,730.60. Following the purchase, the insider now directly owns 3,076,070 shares of the company’s stock, valued at approximately $11,012,330.60. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Walter O. Bigby, Jr. sold 10,000 shares of the firm’s stock in a transaction on Friday, April 22nd. The stock was sold at an average price of $3.76, for a total value of $37,600.00. Following the completion of the transaction, the director now owns 80,000 shares of the company’s stock, valued at approximately $300,800. The disclosure for this sale can be found here. Insiders have acquired a total of 490,763 shares of company stock worth $1,851,976 in the last ninety days. Insiders own 49.50% of the company’s stock.
Several hedge funds and other institutional investors have recently added to or reduced their stakes in RVP. Royal Bank of Canada raised its stake in shares of Retractable Technologies by 29.7% during the 1st quarter. Royal Bank of Canada now owns 13,265 shares of the company’s stock valued at $63,000 after buying an additional 3,037 shares during the last quarter. Keebeck Alpha LP purchased a new position in shares of Retractable Technologies in the 4th quarter valued at about $71,000. NewEdge Advisors LLC purchased a new position in shares of Retractable Technologies in the 1st quarter valued at about $77,000. Quadrant Private Wealth Management LLC purchased a new position in shares of Retractable Technologies in the 4th quarter valued at about $94,000. Finally, Strs Ohio purchased a new position in shares of Retractable Technologies in the 1st quarter valued at about $101,000. Institutional investors and hedge funds own 24.02% of the company’s stock.
About Retractable Technologies (NYSEAMERICAN:RVP)
Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. It offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.
Receive News & Ratings for Retractable Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Retractable Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
International Card Establishment (OTCMKTS:ICRD) vs. BTCS (OTCMKTS:BTCS) Critical Comparison
Armanino Foods of Distinction (OTCMKTS:AMNF) Shares Cross Above 50 Day Moving Average of $3.44